Literature DB >> 15004183

Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis.

Michele M Estabrook1, Dominic L Jack, Nigel J Klein, Gary A Jarvis.   

Abstract

Human mannose-binding lectin (MBL) provides a first line of defense against microorganisms by complement activation and/or opsonization in the absence of specific Ab. This serum collectin has been shown to activate complement when bound to repeating sugar moieties on several microorganisms, including encapsulated serogroup B and C meningococci, which leads to increased bacterial killing. In the present study, we sought to identify the meningococcal cell surface components to which MBL bound and to characterize such binding. Outer membrane complex containing both lipooligosaccharide (LOS) and proteins and LOS from Neisseria meningitidis were examined for MBL binding by dot blot and ELISA. MBL bound outer membrane complex but not LOS. The binding to bacteria by whole-cell ELISA did not require calcium and was not inhibited by N-acetyl-glucosamine or mannose. With the use of SDS-PAGE, immunoblot analysis, and mAbs specific for meningococcal opacity (Opa) proteins and porin proteins, we determined that MBL bound to Opa and porin protein B (porB). The N-terminal amino acid sequences of the two MBL binding proteins confirmed Opa and PorB. Purified PorB inhibited the binding of MBL to meningococci. Escherichia coli with surface-expressed gonococcal Opa bound significantly more MBL than did the control strain. The binding of human factor H to purified PorB was markedly inhibited by MBL in a dose-dependent manner. Meningococci incubated with human serum bound MBL as detected by ELISA. We conclude that MBL binds to meningococci by a novel target recognition of two nonglycosylated outer membrane proteins, Opa and PorB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004183     DOI: 10.4049/jimmunol.172.6.3784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin.

Authors:  S Lear; E Eren; J Findlow; R Borrow; D Webster; S Jolles
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

3.  Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.

Authors:  Morris D Cooper; Melissa H Roberts; Ona L Barauskas; Gary A Jarvis
Journal:  Am J Reprod Immunol       Date:  2012-04-26       Impact factor: 3.886

Review 4.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

5.  Mannose-binding lectin is present in human semen and modulates cellular adhesion of Neisseria gonorrhoeae in vitro.

Authors:  J B Wing; D L Jack; M E Lee; A A Pacey; G R Kinghorn; R C Read
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

6.  C-reactive protein functions as a negative regulator of macrophage activation induced by apoptotic DNA.

Authors:  Weijuan Zhang; Yanxing Cai; Wei Xu; Sidong Xiong
Journal:  Protein Cell       Date:  2011-09-09       Impact factor: 14.870

7.  TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.

Authors:  D N Quan; M D Cooper; J L Potter; M H Roberts; H Cheng; G A Jarvis
Journal:  Mucosal Immunol       Date:  2008-03-05       Impact factor: 7.313

8.  Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies.

Authors:  Bernt Christian Hellerud; Audun Aase; Tove Karin Herstad; Lisbeth Meyer Naess; Lisa Høyem Kristiansen; Anne-Marie Siebke Trøseid; Morten Harboe; Knut Tore Lappegård; Petter Brandtzaeg; E Arne Høiby; Tom Eirik Mollnes
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

Review 9.  Factor H and neisserial pathogenesis.

Authors:  Jo Anne Welsch; Sanjay Ram
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

10.  Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide.

Authors:  Tom Sprong; Anne-Sophie W Møller; Anna Bjerre; Elisabeth Wedege; Peter Kierulf; Jos W M van der Meer; Petter Brandtzaeg; Marcel van Deuren; T E Mollnes
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.